Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 26,350 KRW
Change Today +3,400 / 14.81%
Volume 314.4K
018680 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:11 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

seoul pharma co ltd (018680) Snapshot

Open
23,300
Previous Close
22,950
Day High
26,350
Day Low
23,000
52 Week High
06/2/15 - 26,350
52 Week Low
12/17/14 - 7,640
Market Cap
187.6B
Average Volume 10 Days
191.5K
EPS TTM
-103.00
Shares Outstanding
7.1M
EX-Date
12/29/14
P/E TM
--
Dividend
35.00
Dividend Yield
0.13%
Current Stock Chart for SEOUL PHARMA CO LTD (018680)

Related News

No related news articles were found.

seoul pharma co ltd (018680) Related Businessweek News

No Related Businessweek News Found

seoul pharma co ltd (018680) Details

Seoul Pharma Co., Ltd. manufactures and distributes pharmaceutical products in South Korea. It produces approximately 50 oral solid products in various therapeutic categories, such as respiratory, infective, cardio-vascular, gastro-intestinal, endocrinal, anti-obesity, etc. The company also offers various products, including creams and ointments; tonics, vitamins, and minerals; and others. In addition, it markets SEBRON anti-tussive and acetylcysteine; TORHES-F digestive and trimebutine; DUVELAC probiotics; AUCLATIN an antibiotic, amoxicillin, and potassium clavulanate; DIFLU antifungal and fluconazole; and EXLIP ER dyslipidemic and nicotinic acid products. Further, the company offers SmartFilm Technology to produce orally disintegrating film products; and has research and development pipeline, including NME and IMD. Seoul Pharma Co., Ltd. was founded in 1976 and is based in Seoul, South Korea.

Founded in 1976

seoul pharma co ltd (018680) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

seoul pharma co ltd (018680) Key Developments

Seoul Pharma Co. Ltd., Annual General Meeting, Mar 20, 2015

Seoul Pharma Co. Ltd., Annual General Meeting, Mar 20, 2015., at 08:30 Korea Standard Time. Location: 120 Danwon savings in Ansan (Ansan Chamber of Commerce Auditorium). Agenda: To approve financial statements for the year ended December 31, 2014; to consider appointment of directors; and to consider the approval of director remuneration.

Seoul Pharma Co. Ltd., Annual General Meeting, Mar 21, 2014

Seoul Pharma Co. Ltd., Annual General Meeting, Mar 21, 2014., at 08:30 Korea Standard Time. Location: Kristiansand Chamber of Commerce Auditorium. Agenda: To approve financial statements January 1, 2013 to December 31, 2013; to consider election and re-election of directors; to consider the approval of director remuneration; and to consider other references useful for making investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
018680:KS 26,350.00 KRW +3,400

018680 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 018680.
View Industry Companies
 

Industry Analysis

018680

Industry Average

Valuation 018680 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.5x
Price/Book 5.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEOUL PHARMA CO LTD, please visit www.seoulpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.